HR1193-117 · 117th Congress
Signed into Law
Signed Dec 20, 2022Cardiovascular Advances in Research and Opportunities Legacy Act
Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the hear…
VOTE BREAKDOWN
No recorded floor vote
Most bills never receive a recorded roll-call vote — they're referred to committee and don't advance to the floor. The sponsor and funding context on this page still tells you who is behind it and what industries have a stake.
SPONSORS
Andy Barr
R-KY · Primary
124 COSPONSORS
BIPARTISANSPONSOR FUNDING
Top industries funding Barr
Party & Leadership22%
Securities & Investment17%
Commercial Banks14%
Insurance12%
Real Estate6%
TRAIL AI
HR 1193, the Cardiovascular Advances in Research and Opportunities Legacy Act, was introduced by Representative Andy Barr of Kentucky and addresses cardiovascular disease research and related health initiatives. The bill has been signed into law. Vote data from the legislative process is not yet available.
Based on public voting records. Does not imply causation.
TIMELINE
INTRODUCEDFeb 22, 2021
PASSED SENATEDec 1, 2022
SIGNEDDec 20, 2022
DATA SOURCES
Bill data: Congress.gov · 117th–119th Congress (2021–present)
Vote records: House Clerk / Senate · 2021–present
Reflects public records. Does not imply causation.
